ERG-IN-4
ERG-IN-4 (Compound 12) is an orally active, selective ERG inhibitor with an IC50 of 5.2 μM for hERG. ERG-IN-4 activates PXR. ERG-IN-4 exhibits anticancer activity against MTAP-deleted non-small cell lung cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 3047672-14-7
- Formule: C24H22F3N7O2
- Masse moléculaire:497.47
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
IC50: 5.2 μM for hERG[1]
Chemical Information
-
CAS No. 3047672-14-7
-
Masse moléculaire 497.47
-
Formule C24H22F3N7O2
-
SMILES
CN(N=C1)C2=C1C(N)=NC3=C2C=C(C(N(N(C(C4CC4)=O)C)CC5=NC=C(C(F)(F)F)C=C5)=O)C=C3
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)